cyclothymic disorder
MONDO:0004572
An affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Cyclothymia
Cyclothymia (, siy-kluh-THIY-mee-uh), also known as cyclothymic disorder, psychothemia / psychothymia, bipolar III, affective personality disorder and cyclothymic personality disorder, is a mental and behavioural disorder that involves numerous periods of symptoms of depression and periods of symptoms of elevated mood. These symptoms, however, are not sufficient to indicate a major depressive episode or a manic episode. Symptoms must last for more than one year in children and two years in adults. The cause of cyclothymia is unknown. Risk factors include a family history of bipolar disorder. Cyclothymia differs from bipolar disorder because it does not involve full episodes of major depression or mania. Treatment is generally achieved with counseling and mood stabilizers such as lithium. It is estimated that 0.4–1% of people have cyclothymia at some point in their lives. The disorder's onset typically occurs in late childhood to early adulthood. Males and females are affected equally often.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.